Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levornidazole Disodium Phosphate for Postoperative Intra-Abdominal Infections
NCT06828874Phase 4Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- May 2023
- Primary completion
- Sep 2024
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of levornidazole in intra-abdominal infections (IAI), sponsored by Yangtze River Pharmaceutical Group. Started May 2023; status: completed.
02
Drugs
levornidazole
03
Conditions
intra-abdominal infections (IAI)
Beyond the preview
Go deeper on NCT06828874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06828874.